{"id":7653,"date":"2026-05-08T12:02:30","date_gmt":"2026-05-08T10:02:30","guid":{"rendered":"https:\/\/oncopeptides.com\/?post_type=news&#038;p=7653"},"modified":"2026-05-08T12:22:39","modified_gmt":"2026-05-08T10:22:39","slug":"nylansering-oncopeptalks-som-poddcast","status":"publish","type":"news","link":"https:\/\/oncopeptides.com\/sv\/nyheter\/nylansering-oncopeptalks-som-poddcast\/","title":{"rendered":"Nylansering: Oncopeptalks som poddcast"},"content":{"rendered":"<p>I det h\u00e4r premi\u00e4ravsnittet av <strong>Oncopeptalks <\/strong>i nytt format m\u00f6ter vi <strong>Sofia Hegis<\/strong>, vd f\u00f6r Oncopeptides, f\u00f6r ett samtal om vad bolaget g\u00f6r \u2013 och vad det faktiskt inneb\u00e4r att s\u00e4lja ett avancerat cancerl\u00e4kemedel p\u00e5 den europeiska marknaden.<\/p>\n<p>Vi g\u00e5r tillbaka till grunderna:<\/p>\n<ul data-path-to-node=\"4\">\n<li>Vilket \u00e4r bolagets flaggskeppsl\u00e4kemedel och vilka patienter \u00e4r det till f\u00f6r?<\/li>\n<li>Varf\u00f6r har Oncopeptides lanserat i just Tyskland, \u00d6sterrike, Spanien och Italien och inte i resten av Europa?<\/li>\n<li>Hur l\u00e5ng tid tar det egentligen innan en l\u00e4kare \u00e4r redo att skriva ut ett nytt l\u00e4kemedel till sina sv\u00e5rast sjuka patienter?<\/li>\n<\/ul>\n<p>Ett avsnitt f\u00f6r dig som vill f\u00f6rst\u00e5 Oncopeptides inifr\u00e5n, oavsett om du \u00e4r ny eller har f\u00f6ljt bolaget l\u00e4nge.<\/p>\n<p><iframe style=\"border-radius: 12px;\" src=\"https:\/\/open.spotify.com\/embed\/episode\/27pS5ckVhNo1GinHXgO0oi?utm_source=generator\" width=\"100%\" height=\"352\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\" data-testid=\"embed-iframe\"><\/iframe><\/p>\n","protected":false},"featured_media":7652,"template":"","meta":{"_acf_changed":false},"news_categories":[365],"protected-content":[],"class_list":["post-7653","news","type-news","status-publish","has-post-thumbnail","hentry","news_categories-investerare"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/news\/7653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/media\/7652"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/media?parent=7653"}],"wp:term":[{"taxonomy":"news_categories","embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/news_categories?post=7653"},{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/protected-content?post=7653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}